Dupixent showed significant and clinically meaningful improvements in both esophageal distensibility as well as disease-related structural ...

Please provide your email address to receive an email when new articles are posted on . In patients with moderate to severe eosinophilic asthma, treatment with dexpramipexole depleted blood and tissue ...

New clinical data reinforce Dupixent’s role in treating eosinophilic esophagitis and may support its long-term positioning in ...

Please provide your email address to receive an email when new articles are posted on . Patients with advanced COPD and blood eosinophils of 100 or less had more exacerbations and reduced lung ...

PITTSBURGH--(BUSINESS WIRE)--Knopp Biosciences LLC today reported further clinical and biomarker data demonstrating that reduction in eosinophil count by oral dexpramipexole significantly correlated ...

Recent studies have shown that the eosinophil response to adrenocortical stimulation with intravenously administered ACTH or intramuscular injection of ACTH gel is a much more reliable test of ...

For the first time in published literature, Le Bonheur Children's Hospital and University of Tennessee Health Science Center (UTHSC) researchers showed that a variety of white blood cells known as ...

There is an increased need for potential biomarkers that can identify patients with chronic obstructive pulmonary disease (COPD) who will benefit from treatment involving inhaled corticosteroids (ICS) ...

Eosinophils residing in the airways of mice respond to influenza A virus (IAV) infection through alterations in surface expression of various markers necessary for migration and cellular immunity ...

Bhatt’s study, "Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts,” was recently published in The New England Journal of Medicine. Bhatt and colleagues conducted a multicenter ...